Abstract
We investigated two of the major proposed modes of action of the benzoquinoid ansamycin geldanamycin using a pair of human colon-carcinoma cell lines, BE and HT29. One potential mechanism of action in colorectal cancer is the inhibition of c-Src kinase activity, since this proto-oncogene is hyperexpressed in human large-bowel tumours. Our results show that despite the 9-fold higher level of c-Src kinase activity found in HT29 cells, there was only a 1.4-fold difference in cytotoxicity as compared with BE cells, the latter being the most sensitive. Moreover, even at concentrations of geldanamycin that resulted in cell kill of 80% or more after a 24-h period of exposure, there was no effect on c-Src kinase activity in HT29 cells, although c-Src protein was depleted at supralethal levels of exposure. We also investigated the metabolism of the quinone moiety of geldanamycin by DT-diaphorase, an enzyme that activates certain quinone antibiotics such as mitomycin C and is hyperexpressed in colorectal cancer cells. Geldanamycin was shown to be a substrate for DT-diaphorase present in HT29 cells. However, the lack of a major differential in cytotoxicity between HT29 and BE cells indicates that this is unlikely to be pharmacologically s...Continue Reading
Citations
Nov 5, 2004·Cancer Chemotherapy and Pharmacology·N F SmithP Workman
Sep 1, 2004·Cancer Chemotherapy and Pharmacology·Julie L EisemanMerrill J Egorin
Mar 17, 2004·Biochimica Et Biophysica Acta·Amere Subbarao SreedharPéter Csermely
Mar 20, 2004·Pharmacology & Therapeutics·Amere Subbarao Sreedhar, Peter Csermely
Jan 1, 2003·Cancer Detection and Prevention·Paul Workman
Oct 18, 2000·Free Radical Biology & Medicine·P L Gutierrez
Jan 6, 2000·The Biochemical Journal·S SuttitanamongkolR Polanowska-Grabowska
Nov 24, 1999·Journal of the National Cancer Institute·L R KellandP Workman
Jul 28, 2006·Cold Spring Harbor Symposia on Quantitative Biology·P Workman
Sep 17, 2008·Cancer Research·Andrea K McCollumCharles Erlichman
Jan 5, 2002·Expert Opinion on Biological Therapy·Alison Maloney, Paul Workman
Mar 10, 2010·Free Radical Biology & Medicine·Yuval SamuniJames B Mitchell
Sep 20, 2005·British Journal of Pharmacology·Csaba SõtiPéter Ferdinandy
Feb 8, 2006·Analytical Biochemistry·R HowesM J Drysdale
Jan 26, 2002·Molecular Pharmacology·Ahlke StrassburgRobert H Tukey
Dec 19, 2007·The Journal of Biological Chemistry·Fong-Pin LiangShu-Ling Fu
Aug 30, 2000·Oncogene·P A ClarkeP Workman
Nov 17, 2006·Cancer Research·Andrea K McCollumCharles Erlichman
Dec 3, 2009·Molecular Cancer Therapeutics·Mark DouglasEmmanuel Normant